West Dermatology Research Center
West Dermatology Research Center
San Diego, California, United States8 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3) | DNA Virus Infections, Infections, Skin Diseases, Viral, Skin and Connective Tissue Diseases, Tumor Virus Infections, common wart, human papilloma virus infection, skin disorder, skin disorder caused by infection, viral infectious disease | Recruiting | Phase 3 | 2026-09-03 | NCT07637734 | |
| Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist | Body Weight, Body Weight Changes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Weight Loss, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Not applicable | 2026-04-30 | NCT07558603 | |
| A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria | Chronic Disease, Chronic Spontaneous Urticaria, Disease Attributes, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, chronic urticaria, immune system disorder, skin disorder, skin vascular disease, urticaria | Active, not recruiting | Phase 3 | 2026-03-25 | NCT06445023 | |
| Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines | Facial Laxity; Fine Lines; Volume Loss; Wrinkle | Not yet recruiting | Phase 4 | 2026-02-19 | NCT07421544 | |
| Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias | Leg Veins | Not yet recruiting | Phase 4 | 2026-01-15 | NCT07342413 | |
| Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Phase 2 | 2025-10-28 | NCT07221461 | |
| Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging | Body Weight, Body Weight Changes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, Weight Loss, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Not applicable | 2025-10-28 | NCT07216352 | |
| Assess Impact of Poly-L-lactic Acid on GLP1 Subjects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Not yet recruiting | Phase 2 | 2025-10-16 | NCT07217743 |